Literature DB >> 19589102

Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study.

Hanbyoul Cho1, Mi Kyung Kim, Jae Kwan Lee, Sung Kyong Son, Kwang-Beom Lee, Jong-Min Lee, Jung Pil Lee, Soo Young Hur, Jae-Hoon Kim.   

Abstract

BACKGROUND: Although there have been some epidemiological studies on the effects of diet and nutritional status on cervical carcinogenesis, evidence for a protective effect of antioxidant micronutrients against cervical neoplasia is insufficient. The relationship between serum antioxidant micronutrients and sociodemographic factors and the risk of cervical neoplasia was investigated in this multi-center, case-control study.
METHODS: The study population included women with histopathological diagnosis of cervical intraepithelial neoplasia (CIN) 1 (n=147), CIN 2/3 (n=177), cervical cancer (n=160), and a control group (n=378). Epidemiological data were collected and the serum concentrations of beta-carotene, lycopene, zeaxanthin plus lutein, retinol, alpha-tocopherol, and gamma-tocopherol were measured using reverse-phase, gradient high-pressure liquid chromatography.
RESULTS: Cervical cancer was found to be associated with older age, increased body mass index, and lower socioeconomic status as measured by education level and income. The mean serum concentrations of beta-carotene, lycopene, zeaxanthin plus lutein, retinol, alpha-tocopherol, and gamma-tocopherol of cervical cancer patients were significantly lower than those of control subjects. Odds ratio adjusted for age, smoking status, alcohol consumption, and human papillomavirus infection status revealed a significant gradient of decreasing risk of CIN 1, CIN 2/3, and cervical cancer with increasing serum concentrations of most antioxidant micronutrients.
CONCLUSIONS: The results of this study show an inverse association between serum antioxidant micronutrient concentrations and the risk of cervical neoplasia. These results suggest that antioxidant micronutrients play a role in the prevention of cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589102     DOI: 10.1515/CCLM.2009.221

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  Association between carotenoids and outcome of cervical intraepithelial neoplasia: a prospective cohort study.

Authors:  Takuma Fujii; Naoyoshi Takatsuka; Chisato Nagata; Koji Matsumoto; Akinori Oki; Reiko Furuta; Hiroo Maeda; Toshiharu Yasugi; Kei Kawana; Akira Mitsuhashi; Yasuo Hirai; Tsuyoshi Iwasaka; Nobuo Yaegashi; Yoh Watanabe; Yutaka Nagai; Tomoyuki Kitagawa; Hiroyuki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2012-10-25       Impact factor: 3.402

Review 2.  Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea.

Authors:  Sohee Park; Sun Ha Jee; Hai-Rim Shin; Eun Hye Park; Aesun Shin; Kyu-Won Jung; Seung-Sik Hwang; Eun Shil Cha; Young Ho Yun; Sue Kyung Park; Mathieu Boniol; Paolo Boffetta
Journal:  BMC Cancer       Date:  2014-06-06       Impact factor: 4.430

3.  Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies.

Authors:  Xiaoli Hu; Saisai Li; Lulu Zhou; Menghuang Zhao; Xueqiong Zhu
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

4.  Associations between antioxidant vitamins and the risk of invasive cervical cancer in Chinese women: A case-control study.

Authors:  Liyuan Guo; Hong Zhu; Chengjun Lin; Jianhua Che; Xiujuan Tian; Shiyu Han; Honghui Zhao; Yumei Zhu; Dongwei Mao
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

5.  Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway.

Authors:  Ming-Chao Bi; Richard Rosen; Ren-Yuan Zha; Steven A McCormick; E Song; Dan-Ning Hu
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-10       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.